- Home
- AMAT vs MRK Comparison
AMAT vs MRK Comparison
Compare AMAT & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMAT | MRK |
|---|---|---|
| Founded | 1967 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.4B | 268.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AMAT | MRK |
|---|---|---|
| Price | $319.30 | $107.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 14 |
| Target Price | ★ $285.67 | $114.86 |
| AVG Volume (30 Days) | 6.5M | ★ 11.3M |
| Earning Date | 02-12-2026 | 02-03-2026 |
| Dividend Yield | 0.57% | ★ 3.14% |
| EPS Growth | 0.58 | ★ 58.08 |
| EPS | ★ 8.66 | 7.56 |
| Revenue | $28,368,000,000.00 | ★ $64,235,000,000.00 |
| Revenue This Year | $3.91 | $1.97 |
| Revenue Next Year | $13.99 | $4.71 |
| P/E Ratio | $37.23 | ★ $14.32 |
| Revenue Growth | ★ 4.39 | 1.68 |
| 52 Week Low | $123.74 | $73.31 |
| 52 Week High | $333.03 | $112.90 |
Technical Indicators
Market Signals| Indicator | AMAT | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 52.47 |
| Support Level | $311.07 | $106.93 |
| Resistance Level | $333.03 | $111.97 |
| Average True Range (ATR) | 10.39 | 2.66 |
| MACD | 1.11 | -0.59 |
| Stochastic Oscillator | 74.37 | 9.05 |
Price Performance
Historical ComparisonAbout AMAT Applied Materials Inc.
Applied Materials is the largest semiconductor wafer fabrication equipment manufacturer in the world. It has a broad portfolio spanning nearly every corner of the WFE ecosystem. Applied Materials holds leading market share in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).